Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. - Wikidata - wikimedia - TriplyDB

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial.

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial.

http://www.wikidata.org/entity/Q45737388

about

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients Potentiality of immunotherapy against hepatocellular carcinoma Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus Impact of sustained viral response postcurative therapy of hepatitis C-related hepatocellular carcinoma: a systematic review and meta-analysis.Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial.Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma.Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: a meta-analysis.Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma.Hemodynamics in the portal vein evaluated by pulse wave Doppler ultrasonography in patients with chronic hepatitis C treated with interferon Long-term effects of antiviral therapy in patients with chronic hepatitis C.Prognostic prediction and treatment strategy in hepatocellular carcinoma.Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis.The prognostic significance of clinical and pathological features in hepatocellular carcinoma.Prevention of hepatocellular carcinoma Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma.Direct transformation of lung microenvironment by interferon-α treatment counteracts growth of lung metastasis of hepatocellular carcinoma.Hepatitis C and hepatocellular carcinoma.Antiviral therapy in patients after treatment for hepatitis C-related hepatocellular carcinoma.Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis.Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials.Impact of transarterial therapy in hepatitis C-related hepatocellular carcinoma on long-term outcomes after liver transplantation Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial.Management of hepatocellular cancer.Hepatocellular carcinoma: therapy and prevention.Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes.Improving anti-hepatitis C virus therapy.Multidisciplinary treatment of patients with hepatocellular carcinoma.The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma.A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma.Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan.Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties Immunotherapy for liver tumors: present status and future prospects.Chemoprevention of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis.Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma.Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention.

P2860

Q24241711-7DE183DE-814C-44CA-9AF6-2A1E564F5FCF Q24653596-024AA6CD-0B66-4451-83B2-4156A4C37079 Q26784228-D047F442-A678-4BF6-90E7-DE690B6D58CD Q26829868-D01BBC46-F8D6-4A95-AAF5-61219E32878F Q30241048-03C538F6-B99B-44FE-B003-3368F463B2C3 Q30479629-453ACE36-7292-4720-A34B-543801A25EAA Q33370654-FA475089-9CD7-4340-9B22-9E8A010BCD68 Q33829900-A80EAC10-06F6-4BB4-8FBD-83F00A448B80 Q33920626-2420DE40-7442-4784-88DC-6042B7BF9D0D Q34225588-20716054-0E8E-42C6-97AF-D1929318D8E4 Q34225751-B24BF01D-8BF2-4096-A0DE-4E0C464014C2 Q34382312-27C6A4EC-773F-41AA-9219-B4A7EE283E5A Q34415157-6B0D7133-940D-4E4E-80C8-4BEA4E6DAEC8 Q34547469-EAE064CB-86EE-4DD4-B775-B5AB1AED10AF Q34560811-F4ED0AC4-39F0-4687-B3B9-3EAB0130F5BD Q34572884-59CC07AD-69F6-405E-95AE-81FE2E2F547F Q34582844-00D8447B-682C-409F-8E25-322AF4714080 Q34589307-73C3491E-BF61-4920-B3E5-1633070476E5 Q34611545-E8239FEC-C01D-4218-BAF9-2FD01ABF59EC Q34634386-020A2F12-50B7-4AC9-82A9-94FB91A85859 Q34677919-DE155689-C442-454C-AECE-B5ED8F989C0A Q34725891-C668F1DB-0E8A-4B92-AB4C-54571C046DEB Q34998414-A2F48D1E-CBE1-4ECC-9B4A-532DF86D819B Q35101345-9A57B3CB-C7FB-4B1E-B303-3AF71654F9B3 Q35162986-8BF2608D-0C88-47D8-BF77-200C9007DA45 Q35595548-15ED7430-251D-40EC-8E03-9A86245EBC83 Q35698198-1DC05BDA-BAA0-4FDC-9AE2-4EB60FC857F1 Q36233590-054EFB31-996B-40DF-BA49-7CA4D66917DA Q36377949-925D70D5-FC24-4064-85FF-C610C3814021 Q36497118-A5005EF7-4B7C-4743-BC52-FD3B1FA267B4 Q36569749-77F83A7A-5FC1-4C9D-97ED-B52D77546FDE Q36636630-DFAE6F84-CD3B-4EAD-9348-10347FBEE35B Q36686983-3BDCFFD2-5A12-49B9-A949-08D343186336 Q36934253-8F138683-8C5B-4FAA-A664-799883234109 Q37014868-A1F8EC63-11B2-45B1-ACB1-71D12F69FA32 Q37039311-2B7B0BCF-54FB-4FF9-B77A-4A1398905724 Q37144014-77A415FA-A4F8-490C-8C0D-EC612F82C8A2 Q37266324-61225C22-DD9D-4D7A-9719-4B2147DA24DB Q37278194-280E6381-8265-4857-886D-8DED99DBBB73 Q37345052-4E5A38BE-26C5-4779-8A16-40CF11363E67

P2860

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial.

http://www.wikidata.org/entity/Q45737388

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Effects of long-term postopera ...... randomized, controlled trial.

@en

Effects of long-term postopera ...... randomized, controlled trial.

@nl

type

label

Effects of long-term postopera ...... randomized, controlled trial.

@en

Effects of long-term postopera ...... randomized, controlled trial.

@nl

prefLabel

Effects of long-term postopera ...... randomized, controlled trial.

@en

Effects of long-term postopera ...... randomized, controlled trial.

@nl

P1433

Q45737388-F0335325-49BD-4F98-A6EC-D51E8197A30A

P1476

Q45737388-B21ECFF6-F100-4E7A-B8EF-8DB3E6C100D8

P2093

Q45737388-08DBE4B0-1D2C-4B1B-A070-8F98A317ED85

Q45737388-0A5D894A-1F95-4ECA-8BC8-65E551A1706E

Q45737388-0D625B17-13EB-4FF5-9BAE-F7B163F4AFD9

Q45737388-23CA4A09-9222-40D6-83C4-78367420A82D

Q45737388-59A2DD17-9429-4EEB-BB37-20682BC84CD7

Q45737388-649CA36A-B188-449E-9F59-87073DD53207

Q45737388-72828DD8-C3BA-4403-A407-AB9AEFD8C47B

Q45737388-798A4CD2-F2C0-4AC4-8A07-C5C57774D513

Q45737388-A550B68D-05E1-491A-AC2A-95758B060C31

Q45737388-A6E428E9-0825-4D24-B520-45ADD77C2208

P304

Q45737388-0AE58665-CAA5-4492-ADA2-8C67B76CCE30

P31

Q45737388-BA212ED1-FB31-4EE6-AF77-C76B95581CBE

P356

Q45737388-5971289E-C3F9-4B05-9003-8710343B754F

P407

Q45737388-61893BF3-97C7-446C-BAE2-C9708EFBD123

P433

Q45737388-2F8C8E22-5B80-42C5-9C3B-0F5D3752A382

P478

Q45737388-8D1138B4-17D0-4B4A-93C6-B95C8933E060

P577

Q45737388-3A36B5A4-4E45-40C0-9718-F5D683320484

P698

Q45737388-4718AFFB-17C0-4050-9209-00C77A14AC98

P356

0003-4819-134-10-200105150-00010

P1433

Annals of Internal Medicine

P1476

Effects of long-term postopera ...... randomized, controlled trial.

@en

P2093

Hirohashi K

http://www.w3.org/2001/XMLSchema#string

Igawa S

http://www.w3.org/2001/XMLSchema#string

Kinoshita H

http://www.w3.org/2001/XMLSchema#string

Kubo S

http://www.w3.org/2001/XMLSchema#string

Kuroki T

http://www.w3.org/2001/XMLSchema#string

Nishiguchi S

http://www.w3.org/2001/XMLSchema#string

Oka H

http://www.w3.org/2001/XMLSchema#string

Shiomi S

http://www.w3.org/2001/XMLSchema#string

Shuto T

http://www.w3.org/2001/XMLSchema#string

Tamori A

http://www.w3.org/2001/XMLSchema#string

P304

963-967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-134-10-200105150-00010

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P577

2001-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11352697

http://www.w3.org/2001/XMLSchema#string